Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation

被引:177
作者
Arakawa, R
Yokoyama, S
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem Cell Biol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Grelan Pharmaceut Co Ltd, Div Res & Dev, Tokyo 2050002, Japan
关键词
D O I
10.1074/jbc.M202996200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP-binding cassette transporter (ABC) A1 was increased by apolipoprotein A-I without an increase of its message in THP-1 cells. The pulse label study demonstrated that apoA-I retarded degradation of ABCA1. Similar changes were demonstrated by apoA-II, but the effect of high density lipoprotein was almost negligible on the basis of equivalent protein concentration. Thiol protease inhibitors (leupeptin and N-acetyl-Leu-Leu-norleucinal (ALLN)) increased ABCA1 and slowed its decay in the cells, whereas none of the proteosome-specific inhibitor lactacystin, other protease inhibitors, or the lysosomal inhibitor NH4Cl showed such effects. The effects of apoA-I and ALLN were additive for the increase of ABC.,U,, and the apoA-I-mediated cellular lipid release was enhanced by ALLN. The data suggest that ABCA1 is rapidly degraded by a thiol protease(s) in the cells unless helical apolipoproteins in their lipid-free form stabilize ABCA1 by protecting it from protease-mediated degradation.
引用
收藏
页码:22426 / 22429
页数:4
相关论文
共 31 条
[1]   Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line [J].
Abe-Dohmae, S ;
Suzuki, S ;
Wada, Y ;
Aburatani, H ;
Vance, DE ;
Yokoyama, S .
BIOCHEMISTRY, 2000, 39 (36) :11092-11099
[2]  
Arakawa R, 2000, J LIPID RES, V41, P1952
[3]  
BIELICKI JK, 1992, J LIPID RES, V33, P1699
[4]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[5]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[6]   Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter [J].
Chambenoit, O ;
Hamon, Y ;
Marguet, D ;
Rigneault, H ;
Rosseneu, M ;
Chimini, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :9955-9960
[7]  
COOLICAN SA, 1984, J BIOL CHEM, V259, P1627
[8]  
Costet P, 2000, J BIOL CHEM, V275, P28240
[9]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[10]   DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE [J].
FRANCIS, GA ;
KNOPP, RH ;
ORAM, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :78-87